News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Daily News COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review Todd Neale October 12, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Conference News ACC 2022 Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70 Michael O'Riordan April 07, 2022
News Daily News Strength Training Linked to Less Premature Mortality, CVD, and Diabetes Michael O'Riordan March 02, 2022
News Conference News THT 2022 Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality Caitlin E. Cox February 07, 2022